Recombinant Anti-IL23R × Anti-CD3 Bispecific Antibody (Tandem Diabody) (CAT#: TAND-LC017)

The anti CD3/IL-23R antibody targets both CD3 and IL-23R. By inducing T Cell and mediating target cell lysis, the bispecific antibody can be potentially used in the treatment of cancers such as colorectal cancer.


Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Target
  • IL23R & CD3
  • Type
  • Tandem Diabody
  • Species Reactivity
  • Human
  • Target 1
  • IL23R
  • Host Species 1
  • Human
  • Target 2
  • CD3
  • Host Species 2
  • Human
  • Application
  • FuncS, Promising therapeutic agent
  • Related Disease
  • Colorectal cancer

Target

  • Target 1
  • IL23R
  • Alternative Names
  • IL23R; interleukin 23 receptor
  • Target 2
  • CD3
  • Alternative Names
  • CD3; CD3 T-Cell Co-receptor;CD3D; CD3E; CD3G

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAND-LC017. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare